American biotechnology company Amgen has formalized a collaboration with the Algerian Ministry of Health through the signing of a memorandum of understanding. The partnership focuses on bolstering preventative measures against cardiovascular diseases within Algeria. Details regarding the specific initiatives under this agreement were not immediately available. This collaboration signifies a commitment from both Amgen and the Algerian government to tackle the growing burden of heart-related illnesses in the country. The agreement aims to improve public health outcomes related to cardiovascular health in Algeria. Further information is expected to be released as the partnership develops. The initial announcement appeared on [original source, unspecified in text].